Loading clinical trials...
Loading clinical trials...
The purpose of this trial is to study the effect - in terms of time to progression and overall survival - of 2 years of adjuvant bicalutamide 150mg monotherapy, versus placebo, in subjects with histol...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
AstraZeneca
NCT06202248 · Non-metastatic Prostate Cancer, Locally Recurrent Prostate Cancer
NCT04400656 · Prostate Cancer, Non-metastatic Prostate Cancer, and more
NCT06204302 · Non-metastatic Prostate Cancer, Non-metastatic Castration-resistant Prostate Cancer
Research Site
Birmingham, Alabama
Research Site
Mobile, Alabama
Research Site
Scottsdale, Arizona
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions